Compare WFCF & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WFCF | RFL |
|---|---|---|
| Founded | 1996 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Real Estate |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.5M | 61.1M |
| IPO Year | 2006 | 2017 |
| Metric | WFCF | RFL |
|---|---|---|
| Price | $12.38 | $1.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.0K | ★ 58.8K |
| Earning Date | 06-01-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.28 |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $20,774,416.00 | $917,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $41.67 | ★ N/A |
| Revenue Growth | 16.69 | ★ 43.96 |
| 52 Week Low | $9.69 | $1.12 |
| 52 Week High | $13.70 | $3.19 |
| Indicator | WFCF | RFL |
|---|---|---|
| Relative Strength Index (RSI) | 60.34 | 76.62 |
| Support Level | $10.64 | $1.41 |
| Resistance Level | $12.76 | $1.60 |
| Average True Range (ATR) | 0.16 | 0.07 |
| MACD | 0.13 | 0.02 |
| Stochastic Oscillator | 71.51 | 75.61 |
Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.